First Command Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Command Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-138	Closed	-$17K	–	506
2021 Q4	$17K	Hold	138	–	–	﹤0.01%	336
2021 Q3	$17K	Hold	138	–	–	﹤0.01%	336
2021 Q2	$19K	Hold	138	–	–	﹤0.01%	329
2021 Q1	$19K	Hold	138	–	–	﹤0.01%	314
2020 Q4	$19K	Hold	138	–	–	﹤0.01%	269
2020 Q3	$15K	Buy	+138	New	+$15.5K	﹤0.01%	251
2017 Q1	–	Sell	-111	Closed	-$7K	–	396
2016 Q4	$7K	Buy	+111	New	+$6.85K	0.01%	346

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

First Command Bank's XBI Position: Q1 2022 in Review

First Command Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 138 shares — an estimated $17K sold.

First Command Bank first reported a position in XBI in Q4 2016 and held it in 7 quarters. The position peaked at $19K in Q2 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

First Command Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
First Command Bank sold 138 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $17K.
First Command Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 7 quarters.
First Command Bank's State Street SPDR S&P Biotech ETF position peaked at $19K in Q2 2021.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on First Command Bank's 13F filing for Q1 2022, filed 14 Apr 2022.